Cargando…
Clinical and molecular correlates in fragile X premutation females
The prevalence of the fragile X premutation (55–200 CGG repeats) among the general population is relatively high, but there remains a lack of clear understanding of the links between molecular biomarkers and clinical outcomes. In this study we investigated the correlations between molecular measures...
Autores principales: | Jiraanont, Poonnada, Sweha, Stefan R., AlOlaby, Reem R., Silva, Marisol, Tang, Hiu-Tung, Durbin-Johnson, Blythe, Schneider, Andrea, Espinal, Glenda M., Hagerman, Paul J., Rivera, Susan M., Hessl, David, Hagerman, Randi J., Chutabhakdikul, Nuanchan, Tassone, Flora |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5621595/ https://www.ncbi.nlm.nih.gov/pubmed/28971146 http://dx.doi.org/10.1016/j.ensci.2017.04.003 |
Ejemplares similares
-
Molecular Biomarkers Predictive of Sertraline Treatment Response in Young Children With Autism Spectrum Disorder
por: Alolaby, Reem Rafik, et al.
Publicado: (2020) -
Fragile X Premutation
por: Tassone, Flora, et al.
Publicado: (2014) -
Assessment of Molecular Measures in Non-FXTAS Male Premutation Carriers
por: Al Olaby, Reem R., et al.
Publicado: (2018) -
Neuropsychological changes in FMR1 premutation carriers and onset of fragile X-associated tremor/ataxia syndrome
por: Famula, Jessica, et al.
Publicado: (2022) -
Clinical and Molecular Correlates of Abnormal Changes in the Cerebellum and Globus Pallidus in Fragile X Premutation
por: Wang, Jun Yi, et al.
Publicado: (2022)